Pfizer Inc. offered a rosy outlook for the year, outlining the benefits from the new U.S. tax law and casting the Amazon.com Inc.-led partnership to lower health-care costs as positive for the drug industry.
New York-based Pfizer reported for the fourth quarter a profit of $12.27 billion, or $2.02 a share, up from $775 million, or 13 cents a share, a year earlier. The big gain came largely from a $10.7 billion benefit from the revaluation of deferred tax liabilities.
... 